Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results.
Elif ErtanMustafa DoğanOnur PolatNeriman EfeMüberra AkdoğanSibel İnanReşat DumanRahmi DumanPublished in: Arquivos brasileiros de oftalmologia (2021)
Patients with neovascular age-related macular degeneration who were switched to intravitreal aflibercept treatment due to unresponsiveness to intravitreal ranibizumab exhibited a significant anatomic improvement in the retina, and although this state persisted, there was no significant functional gain.